FindTrial
Sign In

CS-801 phase 3 long-term study

CS-801 phase 3 long-term study

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080220026
Enrollment
Unknown
Registered
2005-09-05
Start date
2005-09-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overactive bladder

Interventions

investigational material(s) Generic name etc : CS-801 INN of investigational material : Therapeutic category code : 259 Other agents for uro-genital and anal organ Dosage and Administration for Inves

Sponsors

Sankyo Co.,Ltd.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria: -Patient, age 20 years or older -Patients with urinary frequency and urge urinary incontinence Exclusion criteria: -Patients who have diseases such as dysuria or urinary retention -Patients who have difficulty to void for myself -Patients with other diseases which may have been related to the state of urination. (ex urinary tract infection) -Patients with polyuria -Patients with diseases for which treatment with anticholinergic agents is contraindicated -Patients in whom precautions are required for the use of anticholinergic agents -Patients who have difficulty to use transdermal medications

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Efficacy and safety—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026